SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global progressive supranuclear palsy treatment market is estimated to be valued at US$ 14.38 million in 2020 and is expected to ...

- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such ...

Prominent civil rights activist Rev. Jesse Jackson was released from a Chicago hospital on Monday after receiving medical ...

Civil rights leader Rev. Jesse Jackson, Sr. has been diagnosed with progressive neurological disease progressive supranuclear palsy, or PSP. What is this rare disease?

The market size of the progressive supranuclear palsy treatment market is expected to experience significant growth in the coming years, as more research is conducted on the disease and new treatments ...

The International PSP Research and Treatment Center (the "Center") will integrate the infrastructure and expertise of the three parties to execute a comprehensive array of functions, including ...

C 2 N Diagnostics and AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted their investigational recombinant humanized anti-tau antibody, C 2 N-8E12 ...

On October 13, GemVax & KAEL announced that it held a plaque unveiling ceremony for the "International Progressive Supranuclear Palsy Research and Treatment Center" at Bundang Seoul National ...